PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cellsNoemi Arrighetti, Laura Gatti, Paola Perego et al.|Toxicology and Applied Pharmacology|2016Cited by 48
Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibitionPaola Perego, Giovanni Luca Beretta, Giacomo Cossa et al.|Biochemical Pharmacology|2011Cited by 45
Differential outcome of MEK1/2 inhibitor-platinum combinations in platinum-sensitive and -resistant ovarian carcinoma cellsGiacomo Cossa, Paola Perego, Cinzia Lanzi et al.|Cancer Letters|2014Cited by 37
Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signalsLaura Gatti, Paola Perego, Alexandra Sevko et al.|Oncotarget|2014Cited by 30